Oncotelic Therapeutics, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Oncotelic Therapeutics, Inc. (OTLC) had Deferred Tax Assets, Operating Loss Carryforwards of $10.38 million as of 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-04-15
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $10.38M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $10.02M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $10.49M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $53.46M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $10.38M 10-K · filed 2026-04-15 | |
| 2024-12-31 | $10.02M 10-K · filed 2026-04-15 | |
| 2023-12-31 | $10.49M 10-K · filed 2025-04-15 | |
| 2022-12-31 | $53.46M 10-K · filed 2024-04-12 | |
| 2021-12-31 | $57.34M 10-K/A · filed 2023-04-20 | |
| 2021-09-30 | $57.15M 10-Q · filed 2021-11-22 | |
| 2021-06-30 | $56.51M 10-Q · filed 2021-08-20 | |
| 2021-03-31 | $55.54M 10-Q · filed 2021-05-24 | |
| 2020-12-31 | $56.09M 10-K · filed 2022-04-15 | $56.09K 10-K · filed 2021-04-15 |
| 2019-12-31 | $58.61K 10-K · filed 2021-04-15 | |
| 2018-12-31 | $56.12M 10-K · filed 2019-04-10 | |
| 2017-12-31 | $55.27M 10-K · filed 2019-04-10 | |
| 2016-12-31 | $85.15M 10-K · filed 2018-04-17 | |
| 2015-12-31 | $83.56M 10-K · filed 2017-03-30 | |
| 2014-12-31 | $79.19M 10-K · filed 2016-03-25 | |
| 2013-12-31 | $74.53M 10-K · filed 2015-03-30 | |
| 2012-12-31 | $72.07M 10-K · filed 2014-03-20 | |
| 2011-12-31 | $71.41M 10-K · filed 2013-03-15 |